Artera vs Hyro
The two established healthcare communication platforms, and they overlap enough that most buyers will see both in the same evaluation. Artera is the broader patient journey platform, orchestrating agents across voice, text and web at very large scale, with named integrations into commercial and federal record systems, the strongest security disclosure in this category, and an unusually explicit account of where automation stops and staff take over. Hyro is the conversational specialist, built for healthcare from inception rather than adapted, concentrated on the inbound question across call centres, websites, text and mobile. The practical split is journey against queue. If your problem is that patients are not answered when they call, Hyro is aimed at it. If it is that nothing coordinates across the appointment, the reminder, the intake and the follow up, Artera is the platform for that.
- Communication reach is the differentiator, with agents across voice, text and web reaching more than a thousand provider organisations at very large volume, and the strongest security disclosure in this category.
- Named integrations across commercial and federal record systems, which is unusual and matters for any organisation with a government facing footprint.
- The autonomy gradient is sold explicitly, with staff able to take over at any point, rather than being left for a buyer to discover in a pilot.
- It was built for healthcare conversation from inception rather than adapted, spanning call centres, websites, text and mobile with a single conversational layer.
- Its focus is the inbound question rather than outbound journey orchestration, which is where the staffing pain in most access centres actually sits.
- For an organisation whose problem is answering the phone rather than coordinating the journey, a conversational platform is the more direct purchase.
Side by Side
| Axis | A Artera |
H Hyro |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Patient Voice Agents page.
Neither vendor publishes a governance framework, model evaluation or subgroup performance analysis, and in patient communication that gap has a specific shape: an agent that performs worse for callers with accents, limited English proficiency or low health literacy fails silently, and those are the patients most likely to need the appointment. Ask both for performance by language and for the escalation rate to a human by caller segment. Neither publishes pricing. Note the name collision in searches: Artera is not ArteraAI, which is a separate oncology company.